Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10661studies shown

Showing 10,117-10,128 of 10,661

Drug study icon

CompletedNCT00186446

Treatment of Addiction and Acute Depression

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Addiction, DepressionDrugOver 18 Years

Countries: United States
Sponsor: Stanford University
Condition: Addiction, Depression

Drug study icon

CompletedNCT00607919

Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 10 Years to 16 Years

Countries: United States
Sponsor: Eli Lilly and Company
Condition: ADHD

Drug study icon

CompletedNCT00080158

Treatment of Adolescent Suicide Attempters (TASA)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 12 Years to 18 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Depression

Drug study icon

CompletedNCT00174226

Treatment of Adult ADHD With Atomoxetine or Atomoxetine and Buspar

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Pfizer
Condition: ADHD

Drug study icon

CompletedNCT00061087

Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: ADHD

Drug study icon

CompletedNCT00043849

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugOver 50 Years

Countries: United States
Sponsor: National Institute on Aging (NIA)
Condition: Schizophrenia

Drug study icon

CompletedNCT01015586

Treatment of Alcohol Dependence and Comorbid Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Bipolarity, Schizophrenia, ...DrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Medical University of South Carolina
Condition: Bipolarity, Schizophrenia, ...

Drug study icon

CompletedNCT01933243

Treatment of Anxiety and Eating disorders in Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disorders, AnxietyDrugFrom 12 Years to 21 Years

Countries: United States
Sponsor: Andrea Bonny
Condition: Eating disorders, Anxiety

Drug study icon

CompletedNCT00018863

Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 3 Years to 5 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: ADHD

Drug study icon

CompletedNCT00510276

Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) With Atomoxetine in Young Adults and Its Effects on Functional Outcomes

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugFrom 18 Years to 30 Years

Countries: United States
Sponsor: Eli Lilly and Company
Condition: ADHD

Drug study icon

CompletedNCT00009217

Treatment of Behavioral Symptoms in Alzheimer's Disease

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 50 Years to 95 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Schizophrenia

Behavioral study icon

CompletedNCT00041743

Treatment of Binge Eating disorders

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersBehavioralFrom 18 Years to 65 Years

Countries: United States
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Condition: Eating disorders

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.